Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Establishment Labs Holdings ( (ESTA) ) has issued an announcement.
On April 30, 2026, Establishment Labs Holdings Inc. amended and restated its existing credit agreement, securing up to $300 million in term loans from lenders led by Oaktree Fund Administration. The new facility, split into a $265 million tranche funded at closing and an additional tranche of up to $35 million, carries an 8.75% interest rate, matures on April 30, 2031, and is largely being used to repay about $259 million of prior debt and related transaction costs.
The agreement tightens the company’s financial framework with minimum liquidity and gross sales covenants, as well as restrictions on additional debt, mergers, and liens, all guaranteed by certain subsidiaries. While the structure offers flexibility through options for payment-in-kind interest and an equity cure right, it also locks in yield protection premiums and exit fees on prepayments, underscoring a more disciplined capital structure and closer lender oversight of the company’s operations and growth trajectory.
The most recent analyst rating on (ESTA) stock is a Buy with a $95.00 price target. To see the full list of analyst forecasts on Establishment Labs Holdings stock, see the ESTA Stock Forecast page.
Spark’s Take on ESTA Stock
According to Spark, TipRanks’ AI Analyst, ESTA is a Neutral.
The score is held down primarily by weak financial performance (ongoing losses and historically heavy cash burn) and a clearly bearish technical setup (below major moving averages with negative MACD). Offsetting these are constructive earnings-call guidance for strong 2026 growth, margin expansion, and improving profitability/cash flow trajectory, but valuation remains constrained by negative earnings and no dividend support.
To see Spark’s full report on ESTA stock, click here.
More about Establishment Labs Holdings
Establishment Labs Holdings Inc. is a medical technology company operating in the healthcare sector, focused on products and solutions related to breast aesthetics and reconstruction. The company targets global markets by providing advanced implant and related technologies, positioning itself as a specialized player within the medical device industry.
Average Trading Volume: 496,365
Technical Sentiment Signal: Buy
Current Market Cap: $1.83B
For an in-depth examination of ESTA stock, go to TipRanks’ Overview page.